[Oral rhinitis therapy in newborn infants].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D012220:Rhinitis / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents; D001205:Ascorbic Acid
Orale Rhinitistherapie bei Frühborenen.